Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicklas Nordborg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMC Bioinformatics|October 14, 2009
BASE--2nd generation software for microarray data management and analysisJohan Vallon-Christersson, Nicklas Nordborg, Martin Svensson, et al.
Genome Medicine|April 14, 2023
Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational studyDeborah F Nacer, Johan Vallon-Christersson, Nicklas Nordborg, et al.
Nature Communications|March 5, 2025
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancerLennart Hohmann, Kristin Sigurjonsdottir, Ana Bosch Campos, et al.
Communications Medicine|February 16, 2026
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancerHelen R Davies, Daniella Black, Anders Kvist, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMC Bioinformatics|October 14, 2009
BASE--2nd generation software for microarray data management and analysisJohan Vallon-Christersson, Nicklas Nordborg, Martin Svensson, et al.
Genome Medicine|April 14, 2023
Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational studyDeborah F Nacer, Johan Vallon-Christersson, Nicklas Nordborg, et al.
Nature Communications|March 5, 2025
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancerLennart Hohmann, Kristin Sigurjonsdottir, Ana Bosch Campos, et al.
Communications Medicine|February 16, 2026
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancerHelen R Davies, Daniella Black, Anders Kvist, et al.
Pageof 1